EP2326253A2 - Integrated surgical sampling probe - Google Patents

Integrated surgical sampling probe

Info

Publication number
EP2326253A2
EP2326253A2 EP09808650A EP09808650A EP2326253A2 EP 2326253 A2 EP2326253 A2 EP 2326253A2 EP 09808650 A EP09808650 A EP 09808650A EP 09808650 A EP09808650 A EP 09808650A EP 2326253 A2 EP2326253 A2 EP 2326253A2
Authority
EP
European Patent Office
Prior art keywords
tissue
medical device
tip
rod
fragments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP09808650A
Other languages
German (de)
French (fr)
Other versions
EP2326253A4 (en
EP2326253B1 (en
Inventor
Ferenc Jolesz
Alexandra Golby
Nathalie Agar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham and Womens Hospital Inc
Original Assignee
Brigham and Womens Hospital Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham and Womens Hospital Inc filed Critical Brigham and Womens Hospital Inc
Publication of EP2326253A2 publication Critical patent/EP2326253A2/en
Publication of EP2326253A4 publication Critical patent/EP2326253A4/en
Application granted granted Critical
Publication of EP2326253B1 publication Critical patent/EP2326253B1/en
Not-in-force legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/02Instruments for taking cell samples or for biopsy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32Surgical cutting instruments
    • A61B17/320068Surgical cutting instruments using mechanical vibrations, e.g. ultrasonic
    • A61B2017/32007Surgical cutting instruments using mechanical vibrations, e.g. ultrasonic with suction or vacuum means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B34/00Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
    • A61B34/20Surgical navigation systems; Devices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
    • A61B2034/2046Tracking techniques
    • A61B2034/2051Electromagnetic tracking systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B34/00Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
    • A61B34/20Surgical navigation systems; Devices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
    • A61B2034/2046Tracking techniques
    • A61B2034/2055Optical tracking systems

Definitions

  • the present invention is directed to medical devices that can be used to obtain tissue samples for diagnostic evaluation and which are integrated with a stereotactic coordinate system so that the exact location of biopsy sites can be determined.
  • the invention includes methods of collecting tissue samples using these devices.
  • Stereotactic surgical procedures were developed in the early 1900's and were first applied clinically in the 1940's (Kelly, P., Neurosurgery 46:16 (2000)). Initially these procedures were used in neurosurgery and involved affixing an external apparatus to a patient's skull to establish a coordinate system for locating, in a reproducible manner, the exact position of a lesion within the intracranial area.
  • stereotactic procedures have been applied to other tissues and are typically used in conjunction with diagnostic imaging procedures such as CT scans and MRIs to map internal tissues, prior to, or during, surgery (see, e.g., Poza, et al., Appl NeurophysioL, 45:482-487 (1985); Dorwald, et al. Br. J. Neurosurg. 75:110-118 (2002); Krieger, et al., J. Surg. Oncol. 14:13-25 (1998)).
  • probes designed to ultrasonically ablate tissue For example, the Cavitron Ultrasonic Surgical Aspirator® (Integra Radionics) uses pulses of ultrasonic energy delivered to a needle-like tip to fragment tissue, which is concurrently irrigated and removed by aspiration.
  • probes of this type were initially designed primarily for the surgical resection of tumors, it was subsequently found that the tissue fragments generated by the devices maintain sufficient integrity to be used diagnostically (Richmond, et al., Neurosurg. 75:415-419 (1983); Malhotra, et al., Acta Neurochir. 57:132-134 (1986); Blackie, et al, J. CHn. Pathol. 37:1101-1104 (2008)).
  • probes such as the Nico MyriadTM probe (NICO Corporation) have been designed to perform surgical ablations by mechanically cutting or shaving tissue.
  • One attractive aspect of these "mechanical sampling” probes is that tissue is obtained without the generation of heat.
  • the present invention is based upon the concept of integrating a tissue resection device with a stereotactic navigation system and then using the device to collect tissue fragments for diagnostic assays. This allows tissue sampling locations to be precisely determined. Preliminary results and published articles reporting on the histopathological evaluation of tissue fragments indicate that ultrasonically generated fragments preserve the features required for standard histopathological diagnosis. It is expected that mechanically generated fragments would also preserve these features.
  • the invention is directed to a medical device (also referred to herein as a "probe") that can be used in collecting tissue samples from biopsy sites in a patient.
  • a medical device also referred to herein as a "probe”
  • Examples of devices that may be adapted for this purpose can be found in US 4,827,911; 4,861,332; 4,660,573; 4,320,761; 4,561,438; 4,169,984; 4,223,676; 4,425,115; and 7,137,963, all of which are incorporated by reference herein in their entirety.
  • the device includes a hand held support, typically made of plastic, metal or rubber with a shape and size that allows it to be easily held and maneuvered in an operator's hand.
  • these supports will have a rectangular or cylindrical shape and be about 4 to 8 inches in length, although other shapes and sizes are possible.
  • Extending from, and attached to, one end of the hand held support is an elongated metal rod with a proximal end (the end attached to the support) and a distal end (the end furthest from the support).
  • the rod will typically be about 3 to 10 inches long and terminate at its distal end in a tip that either itself vibrates in response to ultrasonic energy or which has a separate component attached to it that vibrates in response to ultrasonic energy.
  • the tip may include a sharpened cutting surface that, in response to electrical stimulation, cuts or shaves tissue.
  • the medical device also includes means for supplying ultrasonic energy to the tip or to the separate vibrational component, preferably at a frequency of 15-100 kHz and, more preferably, at 20-60 kHz.
  • Systems for generating ultrasonic vibrations have been known in the art for many years and have been used in many types of devices (see e.g., US Patent Nos. 2,594,841; 3,975,650; 4,736,130; 4,868,445; 5,076,854; 5,276,376; and 5,496,411, all of which are incorporated herein by reference in their entirety).
  • the device may be designed to respond to the input of electrical energy by moving in a manner that results in the cutting or shaving of tissue.
  • the device includes means for supplying irrigating fluid to the distal end of the tip and for aspirating tissue fragments created at the tip as the result of ultrasonic vibrations (see e.g., US 3,693,613; 4,063,557 and 4,827,911, all of which are incorporated by reference herein in their entirety) or due to mechanical cutting or shaving.
  • a preferred method for supplying irrigating fluid is by pumping it from a reservoir through a tubular channel running through the rod and terminating in an opening at the tip. The exact diameter of the channel is not critical to the invention but will typically be between 1/8 and 1/2 of an inch.
  • the reservoir may contain any pharmaceutically acceptable fluid such as water, saline, Ringer's solution etc. and may be maintained at room temperature or chilled, e.g., to 0-15 0 C. If desired, the fluid may also include antibiotics to help prevent infection or other drugs.
  • the metal rod of the device have a hollow core that provides a fluid passageway for tissue fragments.
  • This passageway is open at the tip and extends through or past the hand held support of the device.
  • Sufficient suction is provided, e.g., by means of a medical suction pump, to aspirate material through the opening at the tip in the direction of the hand held support.
  • the diameter of the passageway for aspiration is not critical but will, in general, be between 1/8 and 1/2 inch.
  • the passageway should be connected at its proximal end to a tissue collection container where aspirated fragments are delivered and which, in some embodiments, contains a fluid such as water, saline or Ringer's solution.
  • This fluid may, optionally be chilled, e.g., to 0-10 0 C, and may include chemicals for fixing tissue samples.
  • the tissue fragments may be delivered to a container in which they are quick frozen, e.g., in dry ice or liquid nitrogen. Examples of irrigation and aspiration systems may be found in US 6,723,110; 6,565,535; 4,504,264; 4,531,934; and4,637,814 (all of which are incorporated by reference herein in their entirety) as well as in references cited above.
  • a primary improvement with respect to the present medical device is that it is integrated with a system for stereotactically determining the position of the distal end of the rod (i.e., the location where aspirated tissue samples are collected) relative to the tissue being examined (e.g., brain tissue). Any of the stereotactic positioning systems that are known in the art may be adapted for this purpose.
  • the stereotactic system should include a computer that stores information regarding the spatial relationship between the probe (particularly the tip of the probe) and the tissue of the patient being examined.
  • the probe includes means for communicating information to the computer regarding its position. This may be accomplished using, inter alia: a) ultrasound detectors (see e.g., US 7,251,352; 7,142,905, incorporated by reference herein in their entirety); b) electromagnetic emitters located on the device (preferably on the hand held support of the device) that transmit signals to a separate electromagnetic receiver (see US 7,357,573; 7,313,430, incorporated by reference herein in their entirety); c) sound emitters located on the device (preferably on the hand held support) that transmit signals to microphones (see US 6,374,135, incorporated by reference herein in its entirety); or d) by "optical tracking using infrared energy detectors (see US 7,302,288, incorporated by reference herein in its entirety). In each instance, signals are communicated to the computer for analysis. The most preferred method for communicating information concerning
  • the hand held support includes an actuator switch which, when activated, permits the transmission of ultrasonic or mechanical energy to the tip of the rod or to a separate component which vibrates in response to ultrasonic energy.
  • the switch When the switch is not activated ultrasonic energy is not transmitted.
  • Activation of the actuator switch is, preferably, accompanied by the transmission of a signal to the computer to aid in determining the position of the tip of the rod at the time of actuation.
  • the actuator switch is in the form of a foot pedal which, when activated, transmits ultrasonic energy to the tip of the rod.
  • Actuator switches may also be used which, instead of causing rod tips to ultrasonically vibrate, cause the tip to move in a manner that results in the cutting or shaving of tissue.
  • the invention is directed to a method of collecting a tissue sample from a biopsy site by inserting the tip of any of the medical devices described above into a patient so that the distal end of the rod is positioned at the site where the biopsy is to be performed. Energy is then transmitted to the tip of the rod to create ultrasonic vibrations at the site and fragment tissue or to cause the cutting or shaving of tissue. Irrigation fluid is then administered at the biopsy site and the fragments are aspirated into a collection container where they are retrieved for histological examination or other diagnostic tests.
  • the invention includes methods of collecting tissue samples that are mapped to a particular biopsy site.
  • the first step in these methods is to establish a three dimensional stereotactic coordinate system for reproducibly identifying positions in the tissue that is to be examined, e.g., a portion of a patient's brain or a tumorous growth. Any of the stereotactic positioning systems described in the various references cited above can be used for this purpose.
  • one or more diagnostic imaging procedures e.g., a CT or MRI scan
  • tissue samples are collected using a medical device that fragments the tissue, collects the fragments that have been generated and records the position of sampling in the stereotactic coordinate system.
  • Figure 1 illustrates a type of probe that may be adapted for use in the present invention.
  • the probe disrupts cellular tissue through longitudinal vibration of a hollow tip at ultrasonic frequencies (24 or 35 kHz). Combining the disruption process with irrigation coming from the annular space surrounding the probe assists in removal of the tissue by aspiration through the center of the handpiece into a waste container.
  • the waste container is replaced with a collection container and/or analytical device.
  • the figure shows two electromagnetic sensors (J) that have been located on the hand held support of the device for signaling its position.
  • Figure 2 is a drawing of a device that has a hand held support (K) and an elongated metal rod (L).
  • Figure 3 is an illustration of a hand held support for a device showing a channel for the flow of irrigation fluid (B); and an opening (D) leading into a passageway for aspirated tissue fragments (I).
  • a reservoir of irrigation fluid is represented as (A) and feeds into the channel B through port (G).
  • the aspirated tissue exits the passageway carrying aspirated tissue (I) in a stream (E) passing through port (H) and may be collected in any suitable specimen container.
  • a coupling region (C) where the elongated rod may be attached. In the embodiment shown, attachment is accomplished using threaded bore (M).
  • the figure also shows (F) which represents a cord for transmitting energy that causes the tip of the device to vibrate or move in a manner that results in the cutting or shaving of tissue.
  • Figure 4 shows the terminal part of a device that includes an elongated metal rod L terminating in an opening (N), through which tissue samples may be aspirated.
  • the rod is designed to attach to the hand held support by means of a threaded regions at its base (O) that can be screwed into a matching region in the hand held support (M in Figure 3).
  • the present invention is directed to systems for obtaining tissue samples that record the exact location where each sample is taken.
  • Existing devices that have previously been used primarily for tissue ablation may be adapted for the retrieval of tissue samples and modified so that they integrate with existing systems for the stereotactic positioning of medical devices.
  • Devices that utilize ultrasonic vibrations to fragment tissues and that recover the fragments by aspiration are one type of device that is particularly well suited to the invention because fragments produced in this manner have been shown to retain histological characteristics that can be used diagnostically.
  • An example of such a device is the Cavitron Ultrasonic Surgical Aspirator (CUSA), made by Integra Radionics and similar to the device illustrated in Figure 2.
  • the hand held base unit of the device is shown as (K) with a curved and elongated metal rod (L) extending from it.
  • Devices of this type can be modified by incorporating a component into the hand held support that will provide a signal that can be used in analyzing its exact position.
  • electromagnetic emitters may be included in the support to provide a signal to a separate receiver, which, in turn, communicates this information to a computer for analysis.
  • a drawing of a device with electromagnetic emitters (J) is shown in Figure 1.
  • Other signaling systems include those that detect ultrasonic signals, sound signals and infrared signals.
  • FIG. 3 shows the hand held base unit of a device.
  • (A) represents a reservoir containing irrigation fluid and is connected to a port (G) leading into a channel (B).
  • the channel runs to the distal end of the device where fluid exits and flows or sprays onto tissue.
  • the end of the hand held base unit (C) attaches to the elongated rod (shown in Figure 4) which vibrates at its tip in response to ultrasonic energy provided by an ultrasonic energy generator and transmitted via cord (F).
  • the end of the base unit has an opening (N) that leads into a passageway (I in Figure 3) extending from the tip of the rod to a port (H) at the opposite end of the support unit.
  • This container may contain fluids such as water or saline to preserve the tissue fragments and may optionally be chilled or contain fluid for fixing tissue.
  • Samples recovered from the collection container may then be examined for histological features characteristic of disease or used in other diagnostic tests.
  • the devices described above In order for the devices described above to provide information on the location of sampling sites, they should be integrated with existing systems for the stereotactic analysis of spatial arrangements. Many stereotactic systems have been developed (primarily to aid in neurosurgery) and can readily be adapted for the present invention. The first step in using these systems is to establish a three dimensional stereotactic coordinate system for reproducibly identifying positions in the tissue of the patient.
  • diagnostic imaging procedures e.g., CT scans or MRI scans
  • imaging procedures may be used to provide information on the exact location of a tumor.
  • an important step is the registration step which takes place in the OR.
  • the final step is to use the medical devices described herein to obtain tissue fragments while, at the same time recording the exact position where each sample was collected.
  • the sample from each site is retrieved from the device and diagnostically analyzed.
  • pathologic differences in a tissue may be determined. For example, different sites from tissue containing a tumorous growth may provide information on areas in need of surgical resection and sections that can be spared. This is particularly important in tissues such as the brain where as much normal tissue as possible must be preserved.

Abstract

The present invention is directed to devices for collecting tissue samples from patients. The devices create tissue fragments which are then collected by aspiration. The devices include signal emitters that allow the exact position where a biopsy sample was obtained to be determined. In addition the invention includes methods for obtaining tissue samples using these devices.

Description

Integrated Surgical Sampling Probe
Field of the Invention
The present invention is directed to medical devices that can be used to obtain tissue samples for diagnostic evaluation and which are integrated with a stereotactic coordinate system so that the exact location of biopsy sites can be determined. In addition, the invention includes methods of collecting tissue samples using these devices.
Background of the Invention Stereotactic surgical procedures were developed in the early 1900's and were first applied clinically in the 1940's (Kelly, P., Neurosurgery 46:16 (2000)). Initially these procedures were used in neurosurgery and involved affixing an external apparatus to a patient's skull to establish a coordinate system for locating, in a reproducible manner, the exact position of a lesion within the intracranial area. Today, stereotactic procedures have been applied to other tissues and are typically used in conjunction with diagnostic imaging procedures such as CT scans and MRIs to map internal tissues, prior to, or during, surgery (see, e.g., Poza, et al., Appl NeurophysioL, 45:482-487 (1985); Dorwald, et al. Br. J. Neurosurg. 75:110-118 (2002); Krieger, et al., J. Surg. Oncol. 14:13-25 (1998)).
The development of stereotactic methods and imaging techniques has been accompanied by the development of surgical instruments that allow physicians to perform procedures at sites that were formerly inaccessible. Among the most successful of the instruments that have been developed for neurosurgery are probes designed to ultrasonically ablate tissue. For example, the Cavitron Ultrasonic Surgical Aspirator® (Integra Radionics) uses pulses of ultrasonic energy delivered to a needle-like tip to fragment tissue, which is concurrently irrigated and removed by aspiration. Although probes of this type were initially designed primarily for the surgical resection of tumors, it was subsequently found that the tissue fragments generated by the devices maintain sufficient integrity to be used diagnostically (Richmond, et al., Neurosurg. 75:415-419 (1983); Malhotra, et al., Acta Neurochir. 57:132-134 (1986); Blackie, et al, J. CHn. Pathol. 37:1101-1104 (2008)).
In addition to probes that ablate tissue ultrasonically, probes such as the Nico Myriad™ probe (NICO Corporation) have been designed to perform surgical ablations by mechanically cutting or shaving tissue. One attractive aspect of these "mechanical sampling" probes is that tissue is obtained without the generation of heat.
Despite the advances noted above, the diagnostic use of ultrasonic and mechanical probes has gone largely undeveloped and potential advantages over traditional methods of tissue sampling have often gone unrecognized.
Summary of the Invention
The present invention is based upon the concept of integrating a tissue resection device with a stereotactic navigation system and then using the device to collect tissue fragments for diagnostic assays. This allows tissue sampling locations to be precisely determined. Preliminary results and published articles reporting on the histopathological evaluation of tissue fragments indicate that ultrasonically generated fragments preserve the features required for standard histopathological diagnosis. It is expected that mechanically generated fragments would also preserve these features.
In its first aspect, the invention is directed to a medical device (also referred to herein as a "probe") that can be used in collecting tissue samples from biopsy sites in a patient. Examples of devices that may be adapted for this purpose can be found in US 4,827,911; 4,861,332; 4,660,573; 4,320,761; 4,561,438; 4,169,984; 4,223,676; 4,425,115; and 7,137,963, all of which are incorporated by reference herein in their entirety. The device includes a hand held support, typically made of plastic, metal or rubber with a shape and size that allows it to be easily held and maneuvered in an operator's hand. Typically, these supports will have a rectangular or cylindrical shape and be about 4 to 8 inches in length, although other shapes and sizes are possible. Extending from, and attached to, one end of the hand held support is an elongated metal rod with a proximal end (the end attached to the support) and a distal end (the end furthest from the support). The rod will typically be about 3 to 10 inches long and terminate at its distal end in a tip that either itself vibrates in response to ultrasonic energy or which has a separate component attached to it that vibrates in response to ultrasonic energy. Alternatively the tip may include a sharpened cutting surface that, in response to electrical stimulation, cuts or shaves tissue. The medical device also includes means for supplying ultrasonic energy to the tip or to the separate vibrational component, preferably at a frequency of 15-100 kHz and, more preferably, at 20-60 kHz. Systems for generating ultrasonic vibrations have been known in the art for many years and have been used in many types of devices (see e.g., US Patent Nos. 2,594,841; 3,975,650; 4,736,130; 4,868,445; 5,076,854; 5,276,376; and 5,496,411, all of which are incorporated herein by reference in their entirety). Alternatively the device may be designed to respond to the input of electrical energy by moving in a manner that results in the cutting or shaving of tissue. For example, there may be an electrical motor that causes the tip to rotate in the manner of a drill in response to electrical input.
In addition, the device includes means for supplying irrigating fluid to the distal end of the tip and for aspirating tissue fragments created at the tip as the result of ultrasonic vibrations (see e.g., US 3,693,613; 4,063,557 and 4,827,911, all of which are incorporated by reference herein in their entirety) or due to mechanical cutting or shaving. A preferred method for supplying irrigating fluid is by pumping it from a reservoir through a tubular channel running through the rod and terminating in an opening at the tip. The exact diameter of the channel is not critical to the invention but will typically be between 1/8 and 1/2 of an inch. The reservoir may contain any pharmaceutically acceptable fluid such as water, saline, Ringer's solution etc. and may be maintained at room temperature or chilled, e.g., to 0-150C. If desired, the fluid may also include antibiotics to help prevent infection or other drugs.
With respect to aspiration, it is preferred that the metal rod of the device have a hollow core that provides a fluid passageway for tissue fragments. This passageway is open at the tip and extends through or past the hand held support of the device. Sufficient suction is provided, e.g., by means of a medical suction pump, to aspirate material through the opening at the tip in the direction of the hand held support. As with the channel for providing irrigation fluid, the diameter of the passageway for aspiration is not critical but will, in general, be between 1/8 and 1/2 inch.
The passageway should be connected at its proximal end to a tissue collection container where aspirated fragments are delivered and which, in some embodiments, contains a fluid such as water, saline or Ringer's solution. This fluid may, optionally be chilled, e.g., to 0-100C, and may include chemicals for fixing tissue samples. In an alternative embodiment, the tissue fragments may be delivered to a container in which they are quick frozen, e.g., in dry ice or liquid nitrogen. Examples of irrigation and aspiration systems may be found in US 6,723,110; 6,565,535; 4,504,264; 4,531,934; and4,637,814 (all of which are incorporated by reference herein in their entirety) as well as in references cited above.
A primary improvement with respect to the present medical device is that it is integrated with a system for stereotactically determining the position of the distal end of the rod (i.e., the location where aspirated tissue samples are collected) relative to the tissue being examined (e.g., brain tissue). Any of the stereotactic positioning systems that are known in the art may be adapted for this purpose. Examples of such systems and related materials are described in US 4,618,978; 5,171,296; 5,207,688; 5,311,868; 5,383,454; 5,423,832; 5,531,229; 5,628,315; 5,665,095; 5,690,108; 5,706,811; 5,728,106; 5,947,981; and 6,355,049 (all of which are incorporated by reference herein in their entirety).
The stereotactic system should include a computer that stores information regarding the spatial relationship between the probe (particularly the tip of the probe) and the tissue of the patient being examined. The probe includes means for communicating information to the computer regarding its position. This may be accomplished using, inter alia: a) ultrasound detectors (see e.g., US 7,251,352; 7,142,905, incorporated by reference herein in their entirety); b) electromagnetic emitters located on the device (preferably on the hand held support of the device) that transmit signals to a separate electromagnetic receiver (see US 7,357,573; 7,313,430, incorporated by reference herein in their entirety); c) sound emitters located on the device (preferably on the hand held support) that transmit signals to microphones (see US 6,374,135, incorporated by reference herein in its entirety); or d) by "optical tracking using infrared energy detectors (see US 7,302,288, incorporated by reference herein in its entirety). In each instance, signals are communicated to the computer for analysis. The most preferred method for communicating information concerning the position of the device is with electromagnetic emitters.
In a preferred embodiment, the hand held support includes an actuator switch which, when activated, permits the transmission of ultrasonic or mechanical energy to the tip of the rod or to a separate component which vibrates in response to ultrasonic energy. When the switch is not activated ultrasonic energy is not transmitted. Activation of the actuator switch is, preferably, accompanied by the transmission of a signal to the computer to aid in determining the position of the tip of the rod at the time of actuation. In an alternative and more preferable design, the actuator switch is in the form of a foot pedal which, when activated, transmits ultrasonic energy to the tip of the rod. Actuator switches may also be used which, instead of causing rod tips to ultrasonically vibrate, cause the tip to move in a manner that results in the cutting or shaving of tissue.
In another aspect, the invention is directed to a method of collecting a tissue sample from a biopsy site by inserting the tip of any of the medical devices described above into a patient so that the distal end of the rod is positioned at the site where the biopsy is to be performed. Energy is then transmitted to the tip of the rod to create ultrasonic vibrations at the site and fragment tissue or to cause the cutting or shaving of tissue. Irrigation fluid is then administered at the biopsy site and the fragments are aspirated into a collection container where they are retrieved for histological examination or other diagnostic tests.
The invention includes methods of collecting tissue samples that are mapped to a particular biopsy site. The first step in these methods is to establish a three dimensional stereotactic coordinate system for reproducibly identifying positions in the tissue that is to be examined, e.g., a portion of a patient's brain or a tumorous growth. Any of the stereotactic positioning systems described in the various references cited above can be used for this purpose. Next, one or more diagnostic imaging procedures (e.g., a CT or MRI scan) are performed to identify areas in the patient where one or more biopsy samples may be taken. Finally, tissue samples are collected using a medical device that fragments the tissue, collects the fragments that have been generated and records the position of sampling in the stereotactic coordinate system. The information obtained using this procedure will be particularly useful when multiple sites are sampled, for example, to determine how far cancer cells have invaded. Although the methodology can, in principle be applied to any site in a patient's body, it is expected that, initially, it will be most useful for biopsies involving brain tissue or breast tissue. Brief Description of the Drawings
Figure 1 : Figure 1 illustrates a type of probe that may be adapted for use in the present invention. The probe disrupts cellular tissue through longitudinal vibration of a hollow tip at ultrasonic frequencies (24 or 35 kHz). Combining the disruption process with irrigation coming from the annular space surrounding the probe assists in removal of the tissue by aspiration through the center of the handpiece into a waste container. For the purposes of the present invention, the waste container is replaced with a collection container and/or analytical device. The figure shows two electromagnetic sensors (J) that have been located on the hand held support of the device for signaling its position.
Figure 2: Figure 2 is a drawing of a device that has a hand held support (K) and an elongated metal rod (L).
Figure 3 : Figure 3 is an illustration of a hand held support for a device showing a channel for the flow of irrigation fluid (B); and an opening (D) leading into a passageway for aspirated tissue fragments (I). A reservoir of irrigation fluid is represented as (A) and feeds into the channel B through port (G). The aspirated tissue exits the passageway carrying aspirated tissue (I) in a stream (E) passing through port (H) and may be collected in any suitable specimen container. At the distal end of the hand held support is a coupling region (C) where the elongated rod may be attached. In the embodiment shown, attachment is accomplished using threaded bore (M). The figure also shows (F) which represents a cord for transmitting energy that causes the tip of the device to vibrate or move in a manner that results in the cutting or shaving of tissue.
Figure 4: Figure 4 shows the terminal part of a device that includes an elongated metal rod L terminating in an opening (N), through which tissue samples may be aspirated. In the embodiment shown, the rod is designed to attach to the hand held support by means of a threaded regions at its base (O) that can be screwed into a matching region in the hand held support (M in Figure 3).
Detailed Description of the Invention
The present invention is directed to systems for obtaining tissue samples that record the exact location where each sample is taken. Existing devices that have previously been used primarily for tissue ablation may be adapted for the retrieval of tissue samples and modified so that they integrate with existing systems for the stereotactic positioning of medical devices.
Devices that utilize ultrasonic vibrations to fragment tissues and that recover the fragments by aspiration are one type of device that is particularly well suited to the invention because fragments produced in this manner have been shown to retain histological characteristics that can be used diagnostically. An example of such a device is the Cavitron Ultrasonic Surgical Aspirator (CUSA), made by Integra Radionics and similar to the device illustrated in Figure 2. The hand held base unit of the device is shown as (K) with a curved and elongated metal rod (L) extending from it. Devices of this type can be modified by incorporating a component into the hand held support that will provide a signal that can be used in analyzing its exact position. For example, electromagnetic emitters may be included in the support to provide a signal to a separate receiver, which, in turn, communicates this information to a computer for analysis. A drawing of a device with electromagnetic emitters (J) is shown in Figure 1. Other signaling systems that may be used include those that detect ultrasonic signals, sound signals and infrared signals.
Devices should also include means for irrigating and aspirating tissues after fragmentation. This is illustrated in Figure 3 which shows the hand held base unit of a device. In this figure, (A) represents a reservoir containing irrigation fluid and is connected to a port (G) leading into a channel (B). The channel runs to the distal end of the device where fluid exits and flows or sprays onto tissue. The end of the hand held base unit (C) attaches to the elongated rod (shown in Figure 4) which vibrates at its tip in response to ultrasonic energy provided by an ultrasonic energy generator and transmitted via cord (F).
The end of the base unit has an opening (N) that leads into a passageway (I in Figure 3) extending from the tip of the rod to a port (H) at the opposite end of the support unit.
Aspirated tissue exits this port in a stream (E) and may be delivered to a collection container. This container may contain fluids such as water or saline to preserve the tissue fragments and may optionally be chilled or contain fluid for fixing tissue. Samples recovered from the collection container may then be examined for histological features characteristic of disease or used in other diagnostic tests. In order for the devices described above to provide information on the location of sampling sites, they should be integrated with existing systems for the stereotactic analysis of spatial arrangements. Many stereotactic systems have been developed (primarily to aid in neurosurgery) and can readily be adapted for the present invention. The first step in using these systems is to establish a three dimensional stereotactic coordinate system for reproducibly identifying positions in the tissue of the patient. This is usually accomplished using an apparatus or electrodes that are placed in fixed positions on the patient as a frame of reference. Diagnostic imaging procedures (e.g., CT scans or MRI scans) may then be performed to provide information concerning the internal tissues of the patient and the spatial relationship of the tissues to the established coordinate system. For example, imaging procedures may be used to provide information on the exact location of a tumor. After imaging, an important step is the registration step which takes place in the OR.
The final step is to use the medical devices described herein to obtain tissue fragments while, at the same time recording the exact position where each sample was collected. The sample from each site is retrieved from the device and diagnostically analyzed. In this way, pathologic differences in a tissue may be determined. For example, different sites from tissue containing a tumorous growth may provide information on areas in need of surgical resection and sections that can be spared. This is particularly important in tissues such as the brain where as much normal tissue as possible must be preserved.
Examples
We collected brain tumor specimens using both, surgical forceps and CUSA and then performed histopathological and mass spectrometry analyses. The histopathology showed preservation of histology features required for diagnosis, and the direct mass spectrometry analysis of the tissue specimens using a DESI-LTQ instrument revealed molecular signatures indicative of neoplasia, as compared to specimens biopsied using surgical forceps. This new integrated surgical-sampling probe will enable the differentiation of tumor from non-tumor tissue based on measurements or imaging of the samples.
All references cited herein are fully incorporated by reference. Having now fully described the invention, it will be understood by those of skill in the art that the invention may be performed within a wide and equivalent range of conditions, parameters and the like, without affecting the spirit or scope of the invention or any embodiment thereof.

Claims

What is Claimed is:
1. A medical device comprising: a) a hand held support; b) an elongated metal rod extending from and attached to said hand-held support, wherein said rod terminates at its distal end in a tip that either itself vibrates in response to ultrasonic energy or comprises a separate component which vibrates in response to ultrasonic energy; c) means for supplying ultrasonic energy to said tip or said separate component; d) means for supplying irrigating fluid to said tip; e) means for aspirating tissue fragments created at said tip; f) means for stereotactically determining position of said tip. g) means for collecting tissue samples.
2. The medical device of claim 1, wherein said means for stereotactically determining the position of the tip, comprises one or more electromagnetic emitters located on said device that transmit signals to a separate electromagnetic receiver or infrared energy detectors for optical tracking.
3. The medical device of claim 1 wherein said rod has a hollow core that provides a fluid passageway running along the length of said rod to said tip.
4. The medical device of claim 1, wherein said aspirating means creates suction in said hollow core of said rod to aspirate material through said tip in the direction of said hand held support.
5. The medical device of claim 4, wherein said fluid passageway terminates at its proximal end in a tissue collection container.
6. The medical device of claim 5, wherein said tissue collection container is chilled or comprises a fluid for fixing tissue samples.
7. The medical device of claim 1, wherein said means for supplying ultrasonic energy operates at a frequency of 15-100 kHz.
8. The medical device of claim 1, wherein said means for supplying irrigating fluid comprises a tubular channel running through said rod, wherein said channel is connected at its proximal end to a reservoir of irrigating fluid and wherein said channel terminates at the tip of said rod in an opening through which said irrigating fluid can flow.
9. The medical device of claim 1, wherein said hand held support comprises an actuator switch which, when activated, permits the transmission of ultrasonic energy to the tip of said rod or to said separate component which vibrates in response to ultrasonic energy and which does not permit said transmission when not activated.
10. The medical device of claim 9, wherein, said means for stereotactically determining the position of the distal end of said rod, comprises electromagnetic emitters located on said device that transmit signals to a separate electromagnetic receiver, wherein said electromagnetic receiver communicates signal data to a computer programmed to analyze position or infrared energy detectors for optical tracking.
11. A method of collecting a tissue sample from a biopsy site of a patient comprising: a) inserting the tip of the medical device of any one of claims 1-10 into said patient so that the distal end of said rod is positioned at said biopsy site; b) transmitting ultrasonic energy to the tip of said rod or said separate component which vibrates in response to ultrasonic energy, thereby causing the fragmentation of tissue; c) aspirating the fragments of tissue created in step b) into a collection container; d) retrieving the fragments of tissue from said collection container.
12. A method of collecting from a patient a tissue sample that is mapped to a particular biopsy site, said method comprising: a) establishing a three dimensional stereotactic coordinate system for reproducibly identifying positions in the tissue of said patient; b) performing one or more diagnostic imaging procedures to identify areas where one or more biopsy samples will be taken; c) collecting tissue samples using a medical device that: i) fragments the tissue at specific sites; ii) collects the fragments that have been generated; iii) transmits a signal regarding its position in said stereotactic coordinate system, thereby providing a specific biopsy location.
13. The method of claim 12, wherein said medical device is the medical device of any one of claims 1-10.
14. The method of claim 12, wherein, in step b) said diagnostic imaging procedures include a computed tomography (CT) scan.
15. The method of claim 12, wherein said diagnostic imaging procedures include a magnetic resonance imaging (MRI) scan.
16. The method of claim 15, wherein said is tissue obtained from the brain or breast of said patient.
17. The method of claim 16, wherein said medical device fragments tissues using ultrasonic vibrations.
18. The method of claim 17, wherein said tissue fragments are collected by aspiration.
19. The method of claim 18, wherein said medical device is the medical device of any one of claims 1-10.
20. The method of claim 19, wherein at least one biopsy sample is obtained from a tumor.
EP09808650.7A 2008-08-18 2009-08-17 Integrated surgical sampling probe Not-in-force EP2326253B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13619008P 2008-08-18 2008-08-18
PCT/US2009/053967 WO2010021951A2 (en) 2008-08-18 2009-08-17 Integrated surgical sampling probe

Publications (3)

Publication Number Publication Date
EP2326253A2 true EP2326253A2 (en) 2011-06-01
EP2326253A4 EP2326253A4 (en) 2013-11-27
EP2326253B1 EP2326253B1 (en) 2016-11-23

Family

ID=41707620

Family Applications (1)

Application Number Title Priority Date Filing Date
EP09808650.7A Not-in-force EP2326253B1 (en) 2008-08-18 2009-08-17 Integrated surgical sampling probe

Country Status (3)

Country Link
US (1) US20110144476A1 (en)
EP (1) EP2326253B1 (en)
WO (1) WO2010021951A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2415067B1 (en) * 2009-04-01 2017-12-20 Prosolia, Inc. Method and system for surface sampling
US20110105946A1 (en) * 2009-10-31 2011-05-05 Sorensen Peter L Biopsy system with infrared communications
KR102015149B1 (en) 2011-09-06 2019-08-27 에조노 아게 Imaging Probe and Method of Acquiring Position and / or Orientation Information
WO2014106165A1 (en) 2012-12-30 2014-07-03 Brigham And Women's Hospital, Inc. System and method for analysis of bio-metabolites for-use in image-guided surgery
US9257220B2 (en) 2013-03-05 2016-02-09 Ezono Ag Magnetization device and method
GB201303917D0 (en) 2013-03-05 2013-04-17 Ezono Ag System for image guided procedure
US9459087B2 (en) 2013-03-05 2016-10-04 Ezono Ag Magnetic position detection system
WO2015061597A1 (en) * 2013-10-23 2015-04-30 Brigham And Women's Hospital, Inc. System and method for analyzing tissue intra-operatively using mass spectrometry
WO2018059744A1 (en) * 2016-09-27 2018-04-05 Siemens Aktiengesellschaft Endoscope and method for operating an endoscope

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4750902A (en) * 1985-08-28 1988-06-14 Sonomed Technology, Inc. Endoscopic ultrasonic aspirators
WO2000025692A1 (en) * 1998-11-04 2000-05-11 Trex Medical Corporation Method and apparatus for removing tissue from a region of interest using stereotactic radiographic guidance
US20050049486A1 (en) * 2003-08-28 2005-03-03 Urquhart Steven J. Method and apparatus for performing stereotactic surgery
US20070239153A1 (en) * 2006-02-22 2007-10-11 Hodorek Robert A Computer assisted surgery system using alternative energy technology

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2594841A (en) * 1945-08-11 1952-04-29 Brush Dev Co Piezoelectric transducer with pushpull and feedback circuit
US3693613A (en) * 1970-12-09 1972-09-26 Cavitron Corp Surgical handpiece and flow control system for use therewith
US3975650A (en) * 1975-01-30 1976-08-17 Payne Stephen C Ultrasonic generator drive circuit
US4063557A (en) 1976-04-01 1977-12-20 Cavitron Corporation Ultrasonic aspirator
US4169984A (en) 1976-11-30 1979-10-02 Contract Systems Associates, Inc. Ultrasonic probe
US4223676A (en) * 1977-12-19 1980-09-23 Cavitron Corporation Ultrasonic aspirator
US4425115A (en) * 1977-12-19 1984-01-10 Wuchinich David G Ultrasonic resonant vibrator
US4320761A (en) 1979-02-06 1982-03-23 Haddad Heskel M Surgical device for excision of tissue
GB2116045B (en) * 1982-03-04 1985-01-23 Wolf Gmbh Richard Piezoelectric transducers having a curved tubular shaft for disintegrating calculi
SU1050702A1 (en) 1982-04-13 1983-10-30 Горьковский государственный медицинский институт им.С.М.Кирова Device for breaking and aspirating cataracta
US4504264A (en) * 1982-09-24 1985-03-12 Kelman Charles D Apparatus for and method of removal of material using ultrasonic vibraton
US4618978A (en) * 1983-10-21 1986-10-21 Cosman Eric R Means for localizing target coordinates in a body relative to a guidance system reference frame in any arbitrary plane as viewed by a tomographic image through the body
US4637814A (en) * 1985-04-05 1987-01-20 Arnold Leiboff Method and apparatus for intestinal irrigation
US4660573A (en) * 1985-05-08 1987-04-28 Fibra-Sonics, Inc. Ultrasonic lithotriptor probe
US4827911A (en) 1986-04-02 1989-05-09 Cooper Lasersonics, Inc. Method and apparatus for ultrasonic surgical fragmentation and removal of tissue
US4861332A (en) * 1986-04-14 1989-08-29 Ultramed Corporation Ultrasonic probe
US4736130A (en) 1987-01-09 1988-04-05 Puskas William L Multiparameter generator for ultrasonic transducers
GB8728150D0 (en) * 1987-12-02 1988-01-06 Inst Of Neurology Queen Square Head fixation apparatus
US4868445A (en) 1988-06-20 1989-09-19 Wand Saul N Self tuned ultrasonic generator system having wide frequency range and high efficiency
JP2832443B2 (en) 1988-11-22 1998-12-09 本多電子株式会社 Multi-frequency ultrasonic cleaning method and cleaning apparatus
DE69133603D1 (en) * 1990-10-19 2008-10-02 Univ St Louis System for localizing a surgical probe relative to the head
US5947981A (en) 1995-01-31 1999-09-07 Cosman; Eric R. Head and neck localizer
US5496411A (en) 1991-06-14 1996-03-05 Halcro Nominees Pty. Ltd. Ultrasonic vibration generator and use of same for cleaning objects in a volume of liquid
US5171296A (en) 1991-08-02 1992-12-15 Northwestern University Stereotaxic headring fixation system and method
US5207688A (en) 1991-10-31 1993-05-04 Medco, Inc. Noninvasive head fixation method and apparatus
US5276376A (en) 1992-06-09 1994-01-04 Ultrasonic Power Corporation Variable frequency ultrasonic generator with constant power output
US5311868A (en) * 1992-10-07 1994-05-17 Peachtree Research & Development, Inc. Holder for stereotactic frame
US5728106A (en) * 1993-04-16 1998-03-17 Oregon Neuro-Medical Technology, Inc. Radio-transparent system for stereotactic radiosurgery and fractionated radiation therapy
US5645537A (en) * 1993-04-20 1997-07-08 Advanced Cytometrix, Inc. Aspiration needle and syringe for use therewith, apparatus incorporating the same and kit for use in fine needle aspiration cytology, and method
DE69432834T2 (en) * 1993-04-26 2004-05-13 St. Louis University Display of the location of a surgical probe
US5423832A (en) 1993-09-30 1995-06-13 Gildenberg; Philip L. Method and apparatus for interrelating the positions of a stereotactic Headring and stereoadapter apparatus
DE4432890B4 (en) 1994-09-15 2004-02-19 Brainlab Ag Device for detecting the position of irradiation target points
DE69530355D1 (en) 1994-11-28 2003-05-22 Ohio State University Columbus Medical intervention device
JP2611188B2 (en) 1994-11-30 1997-05-21 工業技術院長 Biological measurement reference point setting method and apparatus
US5665095A (en) 1994-12-15 1997-09-09 Jacobson; Robert E. Stereotactic guidance device
US5531229A (en) * 1995-01-20 1996-07-02 Dean; Richard D. Body part immobilization device
JP3810156B2 (en) * 1996-11-07 2006-08-16 オリンパス株式会社 Suction biopsy tool
US7302288B1 (en) 1996-11-25 2007-11-27 Z-Kat, Inc. Tool position indicator
WO1998051255A1 (en) * 1997-05-15 1998-11-19 Matsushita Electric Works, Ltd. Ultrasonic device
US6322522B1 (en) * 1997-09-22 2001-11-27 Zimmon Science Corp. Apparatus for separable external serial collection, storage and processing of biopsy specimens
US6298262B1 (en) * 1998-04-21 2001-10-02 Neutar, Llc Instrument guidance for stereotactic surgery
US20080146965A1 (en) * 2003-08-11 2008-06-19 Salvatore Privitera Surgical Device for The Collection of Soft Tissue
CA2287087C (en) * 1998-10-23 2007-12-04 Ethicon Endo-Surgery, Inc. Surgical device for the collection of soft tissue
US7189206B2 (en) * 2003-02-24 2007-03-13 Senorx, Inc. Biopsy device with inner cutter
US6524251B2 (en) * 1999-10-05 2003-02-25 Omnisonics Medical Technologies, Inc. Ultrasonic device for tissue ablation and sheath for use therewith
JP4363719B2 (en) * 1999-10-08 2009-11-11 オリンパス株式会社 Ultrasound-guided puncture system device
US6565535B2 (en) 2000-06-16 2003-05-20 Nardo Zaias Medical infusion and aspiration system
US6540679B2 (en) 2000-12-28 2003-04-01 Guided Therapy Systems, Inc. Visual imaging system for ultrasonic probe
US6723110B2 (en) * 2001-04-19 2004-04-20 Synergetics, Inc. High efficiency ultrasonic surgical aspiration tip
US7251352B2 (en) * 2001-08-16 2007-07-31 Siemens Corporate Research, Inc. Marking 3D locations from ultrasound images
US6756586B2 (en) * 2001-10-15 2004-06-29 Vanderbilt University Methods and apparatus for analyzing biological samples by mass spectrometry
US7137963B2 (en) * 2002-08-26 2006-11-21 Flowcardia, Inc. Ultrasound catheter for disrupting blood vessel obstructions
US7322929B2 (en) * 2003-06-18 2008-01-29 Xoft, Inc. Method for radiation treatment
FR2862861B1 (en) * 2003-11-28 2006-12-22 Ge Med Sys Global Tech Co Llc POSITIONING OBJECTS FOR THE ACQUISITION OF IMAGES
US8343071B2 (en) * 2004-12-16 2013-01-01 Senorx, Inc. Biopsy device with aperture orientation and improved tip
US20080050814A1 (en) * 2006-06-05 2008-02-28 Cryo-Cell International, Inc. Procurement, isolation and cryopreservation of fetal placental cells
US20080221479A1 (en) * 2007-03-07 2008-09-11 Ritchie Paul G Integrated Imaging and Biopsy System with Integrated Utilities

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4750902A (en) * 1985-08-28 1988-06-14 Sonomed Technology, Inc. Endoscopic ultrasonic aspirators
WO2000025692A1 (en) * 1998-11-04 2000-05-11 Trex Medical Corporation Method and apparatus for removing tissue from a region of interest using stereotactic radiographic guidance
US20050049486A1 (en) * 2003-08-28 2005-03-03 Urquhart Steven J. Method and apparatus for performing stereotactic surgery
US20070239153A1 (en) * 2006-02-22 2007-10-11 Hodorek Robert A Computer assisted surgery system using alternative energy technology

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2010021951A2 *

Also Published As

Publication number Publication date
WO2010021951A3 (en) 2010-04-22
EP2326253A4 (en) 2013-11-27
EP2326253B1 (en) 2016-11-23
US20110144476A1 (en) 2011-06-16
WO2010021951A2 (en) 2010-02-25

Similar Documents

Publication Publication Date Title
EP2326253B1 (en) Integrated surgical sampling probe
EP1356774B1 (en) Method for using an MRI compatible biopsy device with detachable probe prior to biopsy
EP1872726B1 (en) Energy biopsy device for tissue penetration and hemostasis
JP5639593B2 (en) Real-time pathological diagnosis
US6258104B1 (en) Method and apparatus for removing tissue from a region of interest using stereotactic radiographic guidance
US7826883B2 (en) Localization mechanism for an MRI compatible biopsy device
EP1356772B1 (en) MRI compatible biopsy device with detachable probe
US7438692B2 (en) Localization mechanism for an MRI compatible biopsy device
JP4653172B2 (en) Endoscopic treatment tool and biological tissue analysis processing system
US20030018281A1 (en) Surgical biopsy device having a flexible cutter
US20040267121A1 (en) Device and method for biopsy guidance using a tactile breast imager
US20110201965A1 (en) MRI Compatible Biopsy Device
Donahue Ultrasound-guided breast biopsy tissue sampling: technique and breast ultrasound characteristics of benign and malignant lesions
EP1820453B1 (en) An MRI compatible biopsy device with detachable probe
CN114587591A (en) Optical fiber photoacoustic guiding surgical device
MXPA00006601A (en) Method and apparatus for removing tissue from a region of interest using stereotacticradiographic guidance

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20110317

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

AX Request for extension of the european patent

Extension state: AL BA RS

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20131029

RIC1 Information provided on ipc code assigned before grant

Ipc: A61B 18/00 20060101ALI20131023BHEP

Ipc: A61B 6/00 20060101ALI20131023BHEP

Ipc: A61M 1/00 20060101ALI20131023BHEP

Ipc: A61B 10/02 20060101AFI20131023BHEP

Ipc: A61B 5/055 20060101ALI20131023BHEP

17Q First examination report despatched

Effective date: 20150922

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20160614

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 847116

Country of ref document: AT

Kind code of ref document: T

Effective date: 20161215

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602009042670

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161123

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20161123

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 847116

Country of ref document: AT

Kind code of ref document: T

Effective date: 20161123

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161123

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170223

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161123

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161123

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170224

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161123

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161123

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170323

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161123

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161123

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161123

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161123

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161123

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161123

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161123

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161123

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602009042670

Country of ref document: DE

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 9

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170223

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161123

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161123

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161123

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20170825

Year of fee payment: 9

Ref country code: GB

Payment date: 20170829

Year of fee payment: 9

Ref country code: DE

Payment date: 20170829

Year of fee payment: 9

26N No opposition filed

Effective date: 20170824

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161123

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161123

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170831

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170831

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170817

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170817

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170817

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 602009042670

Country of ref document: DE

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20180817

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20090817

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190301

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180831

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20161123

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180817

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161123

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161123

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170323